LCS3 is a reversible and non-competitive synergistic inhibitor of glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50s of 3.3 µM and 3.8 µM, respectively. LCS3 has antitumour activity, induces apoptosis and can be used in the study of lung adenocarcinoma (LUAD).
Molecular Weight:
266.64
Purity:
99.84%
CAS Number:
[109844-92-0]
Formula:
C11H7ClN2O4
Target:
Apoptosis|||Glutathione reductase
T60446
* VAT and and shipping costs not included. Errors and price changes excepted